TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Enlivex ( (ENLV) ) just unveiled an announcement.
On November 24, 2025, Enlivex Therapeutics Ltd. completed a $212 million private placement, marking a significant step in its strategic expansion into digital asset treasury operations through the RAIN token. The funds will support the company’s cryptocurrency treasury strategy and ongoing clinical development of Allocetra™. The appointment of Matteo Renzi, former Prime Minister of Italy, to the Board of Directors underscores Enlivex’s commitment to innovation and strategic leadership. Renzi’s expertise is expected to enhance the company’s positioning in both the biotech and digital asset sectors.
The most recent analyst rating on (ENLV) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Enlivex stock, see the ENLV Stock Forecast page.
Spark’s Take on ENLV Stock
According to Spark, TipRanks’ AI Analyst, ENLV is a Underperform.
Enlivex’s financial challenges, characterized by no revenue and ongoing cash burn, significantly impact its stock score. Technical indicators show neutral momentum, but the negative valuation metrics reflect ongoing financial difficulties. The absence of positive corporate events or earnings call data limits the potential for a higher score.
To see Spark’s full report on ENLV stock, click here.
More about Enlivex
Enlivex Therapeutics Ltd. is a clinical-stage company specializing in macrophage reprogramming immunotherapy. The company is focused on the late-stage clinical development of Allocetra™, a novel therapy for osteoarthritis, a prevalent joint disease with significant unmet medical needs. Enlivex is also pioneering a digital asset treasury strategy centered around the RAIN token, a decentralized predictions and options protocol.
Average Trading Volume: 3,509,122
Technical Sentiment Signal: Sell
Current Market Cap: $23.38M
For detailed information about ENLV stock, go to TipRanks’ Stock Analysis page.